Literature DB >> 21191047

Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay.

Soumitesh Chakravorty1, Bola Aladegbami, Kimberley Thoms, Jong Seok Lee, Eun Gae Lee, Vignesh Rajan, Eun-Jin Cho, Hyunchul Kim, Hyunkyung Kwak, Natalia Kurepina, Sang-Nae Cho, Barry Kreiswirth, Laura E Via, Clifton E Barry, David Alland.   

Abstract

Fluoroquinolones (FQ) are important second-line drugs to treat tuberculosis; however, FQ resistance is an emerging problem. Resistance has been mainly attributed to mutations in a 21-bp region of the Mycobacterium tuberculosis gyrA gene, often called the quinolone resistance-determining region (QRDR). We have developed a simple, rapid, and specific assay to detect FQ resistance-determining QRDR mutations. The assay amplifies the M. tuberculosis gyrA QRDR in an asymmetrical PCR followed by probing with two sloppy molecular beacons (SMBs) spanning the entire QRDR. Mutations are detected by melting temperature (T(m)) shifts that occur when the SMBs bind to mismatched sequences. By testing DNA targets corresponding to all known QRDR mutations, we found that one or both of the SMBs produced a T(m) shift of at least 3.6°C for each mutation, making mutation detection very robust. The assay was also able to identify mixtures of wild-type and mutant DNA, with QRDR mutants identified in samples containing as little as 5 to 10% mutant DNA. The assay was blindly validated for its ability to identify the QRDR mutations on DNA extracted from clinical M. tuberculosis strains. Fifty QRDR wild-type samples, 34 QRDR mutant samples, and 8 heteroresistant samples containing mixtures of wild-type and mutant DNA were analyzed. The results showed 100% concordance to conventional DNA sequencing, including a complete identification of all of the mixtures. This SMB T(m) shift assay will be a valuable molecular tool to rapidly detect FQ resistance and to detect the emergence of FQ heteroresistance in clinical samples from tuberculosis patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191047      PMCID: PMC3067712          DOI: 10.1128/JCM.02271-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.

Authors:  Jean-Noël Dauendorffer; Isabelle Guillemin; Alexandra Aubry; Chantal Truffot-Pernot; Wladimir Sougakoff; Vincent Jarlier; Emmanuelle Cambau
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Tuberculosis drug resistance comes full circle.

Authors:  Lee B Reichman
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

4.  Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.

Authors:  E R Grimaldo; T E Tupasi; A B Rivera; M I Quelapio; R C Cardaño; J O Derilo; V A Belen
Journal:  Int J Tuberc Lung Dis       Date:  2001-06       Impact factor: 2.373

5.  Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.

Authors:  Amy Sarah Ginsburg; Ronggai Sun; Heather Calamita; Cherise P Scott; William R Bishai; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.

Authors:  Federico Giannoni; Elisabetta Iona; Federica Sementilli; Lara Brunori; Manuela Pardini; Giovanni Battista Migliori; Graziella Orefici; Lanfranco Fattorini
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 7.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.

Authors:  I Guillemin; V Jarlier; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity.

Authors:  Gilla Kaplan; Frank A Post; Andre L Moreira; Helen Wainwright; Barry N Kreiswirth; Melike Tanverdi; Barun Mathema; Srinivas V Ramaswamy; Gabi Walther; Lafras M Steyn; Clifton E Barry; Linda-Gail Bekker
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases.

Authors:  Stefan H Blaas; Ralf Mütterlein; Johannes Weig; Albert Neher; Bernd Salzberger; Norbert Lehn; Ludmila Naumann
Journal:  BMC Infect Dis       Date:  2008-05-02       Impact factor: 3.090

View more
  31 in total

1.  Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding.

Authors:  Soumitesh Chakravorty; Harsheel Kothari; Bola Aladegbami; Eun Jin Cho; Jong Seok Lee; Sandy S Roh; Hyunchul Kim; Hyungkyung Kwak; Eun Gae Lee; Soo Hee Hwang; Padmapriya P Banada; Hassan Safi; Laura E Via; Sang-Nae Cho; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

2.  Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis.

Authors:  Tao Luo; Lili Jiang; Weiming Sun; G Fu; Jian Mei; Qian Gao
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

3.  Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis.

Authors:  Siyu Hu; Guoli Li; Hui Li; Xiaoli Liu; Jianjun Niu; Shengmao Quan; Feng Wang; Huixin Wen; Ye Xu; Qingge Li
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

4.  Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.

Authors:  M-S Hong; Y Kim; E-J Cho; J-S Lee; H-K Kwak; J-H Kim; C-T Kim; J-S Cho; S-K Park; D Jeon; Y-I Choi; H Lee; S-Y Eum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-15       Impact factor: 3.267

5.  Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.

Authors:  Soumitesh Chakravorty; Jong Seok Lee; Eun Jin Cho; Sandy S Roh; Laura E Smith; Jiim Lee; Cheon Tae Kim; Laura E Via; Sang-Nae Cho; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2014-10-22       Impact factor: 5.948

6.  Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.

Authors:  Nicola M Zetola; Sanghyuk S Shin; Kefentse A Tumedi; Keletso Moeti; Ronald Ncube; Mark Nicol; Ronald G Collman; Jeffrey D Klausner; Chawangwa Modongo
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

7.  Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.

Authors:  Yuan Cao; Heta Parmar; David Alland; Soumitesh Chakravorty; Rajiv L Gaur; Deanna Lieu; Shobana Raghunath; Nova Via; Simone Battaglia; Daniela M Cirillo; Claudia Denkinger; Sophia Georghiou; Robert Kwiatkowski; David Persing
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

8.  Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.

Authors:  Anna Engström; Nora Morcillo; Belen Imperiale; Sven E Hoffner; Pontus Juréen
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

9.  Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.

Authors:  Qingyun Liu; Tao Luo; Jing Li; Jian Mei; Qian Gao
Journal:  J Antimicrob Chemother       Date:  2013-01-03       Impact factor: 5.790

10.  Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.

Authors:  Gang Sun; Tao Luo; Chongguang Yang; Xinran Dong; Jing Li; Yongqiang Zhu; Huajun Zheng; Weidong Tian; Shengyue Wang; Clifton E Barry; Jian Mei; Qian Gao
Journal:  J Infect Dis       Date:  2012-09-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.